5-methoxy-N,N-dimethyltryptamine crystalline forms
AssigneeSmall Pharma Ltd
InventorsPeter Rands, Marie Claire Layzell
Life of this patent
Estimating the term…
Abstract
Described herein are crystalline fumarate salts having a Formula I, pharmaceutical formulations comprising the same, methods for their production, and uses thereof, Formula I comprising: wherein each R1 is independently selected from protium and deuterium; each R2 is independently selected from protium and deuterium; each R3 is independently selected from protium and deuterium; and each R4 is independently selected from protium and deuterium; and wherein the compound has a PXRD pattern comprising characteristic peaks at 19.2±0.2 and 24.7±0.2 degrees 2-theta.
Claims19
A crystalline fumarate salt of a compound having a Formula I :
- wherein:
- each R1 is independently selected from protium and deuterium;
- each R2 is independently selected from protium and deuterium;
- each R3 is independently selected from protium and deuterium;
- and
- each R4 is independently selected from protium and deuterium;
- and
- wherein the crystalline fumarate salt has a PXRD pattern comprising characteristic peaks at 19.2±0.2 and 24.7±0.2 degrees 2-theta.
Dependencies are inferred from the claim text.